SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the
Securities Exchange Act of 1934
Date of Report (date of earliest event reported):
July 29,
2004
HARVARD BIOSCIENCE, INC.
(Exact Name of Registrant as specified in its charter)
|
Delaware |
|
0-31923 |
|
04-3306140 |
|
(State or other
jurisdiction |
|
(Commission File |
|
(I.R.S. Employer |
|
|
||||
|
84 October Hill Road, Holliston, MA 01746-1371 |
||||
|
(Address of principal executive offices and zip code) |
||||
|
|
||||
|
(508) 893-8999 |
||||
|
(Registrant’s telephone number, including area code) |
||||
ITEM 7. EXHIBITS
(c) Exhibits. The following exhibits are being furnished herewith:
|
Exhibit |
|
Title |
|
|
|
|
|
99.1 |
|
Press release of Harvard Bioscience, Inc. issued on July 29, 2004 |
ITEM 12. RESULTS OF OPERATIONS AND FINANCIAL CONDITION
On July 29, 2004, Harvard Bioscience, Inc. issued a press release announcing its financial results for the quarter ended June 30, 2004. Copies of Harvard Bioscience, Inc.’s press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.
[Remainder of page intentionally left blank]
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
Dated: July 30, 2004 |
HARVARD BIOSCIENCE, INC. |
||
|
|
|
|
|
|
|
|
|
|
|
|
By: |
/s/ Susan M. Luscinski |
|
|
|
|
Susan M. Luscinski |
|
|
|
|
Chief Financial Officer |
|
3
EXHIBIT INDEX
|
Exhibit |
|
Title |
|
|
|
|
|
99.1 |
|
Press release of Harvard Bioscience, Inc. issued on July 29, 2004 |
4